Q32 Bio Inc. (QTTB) Amortization of Deferred Charges (2023 - 2026)

Q32 Bio has reported Amortization of Deferred Charges for 4 years, with the latest figure at -$67000.0 in Q2 2026.

• On a quarterly basis, Amortization of Deferred Charges fell 236.73% year-over-year to -$67000.0 in Q2 2026; TTM through Jun 2026 was $49000.0, a 75.0% decrease from a year earlier, with the FY2025 full-year figure at $180000.0, down 7.22% from the prior year.
• Amortization of Deferred Charges was -$67000.0 for Q2 2026 at Q32 Bio, down from $33000.0 in the prior quarter.
• The five-year high for Amortization of Deferred Charges was $66000.0 in Q2 2024, with the low at -$67000.0 in Q2 2026.
• Average Amortization of Deferred Charges over 4 years is $30500.0, with a median of $35000.0 recorded in 2025.
• The sharpest annual moves came in 2024 and 2026: Amortization of Deferred Charges surged 614.29% in 2024, then tumbled 236.73% in 2026.
• Over 4 years, Amortization of Deferred Charges stood at $30000.0 in 2023, then jumped by 63.33% to $49000.0 in 2024, then dropped by 24.49% to $37000.0 in 2025, then sank by 281.08% to -$67000.0 in 2026.
• The last three Amortization of Deferred Charges figures came in at -$67000.0 (Q2 2026), $33000.0 (Q1 2026), and $37000.0 (Q4 2025), per Business Quant data.